"RespiraRelief: S PHYLLIN N"

May 17, 2024

S PHYLLIN N

Acebrophylline (100mg), Acetylcysteine (600mg)

S PHYLLIN N combination of Acebrophylline (100mg) and Acetylcysteine (600mg), encapsulated in the formulation of S PHYLLIN N, represent a potent combination therapy aimed at improving respiratory function and alleviating symptoms associated with conditions such .This article delves into the therapeutic benefits of acebrophylline and acetylcysteine, shedding light on their mechanism of action, advantages, and optimal usage guidelines.

Understanding Acebrophylline (100mg) and Acetylcysteine (600mg):

  • Acebrophylline (100mg): Acebrophylline is a bronchodilator and mucolytic agent that acts by reducing airway inflammation, improving mucociliary clearance, and enhancing bronchial relaxation. It helps in alleviating symptoms such as cough, breathlessness, and wheezing, thereby improving respiratory function.
  • Acetylcysteine (600mg): Acetylcysteine, a mucolytic agent, works by breaking down disulfide bonds in mucus, resulting in reduced viscosity and improved expectoration. It aids in clearing mucus from the airways, promoting effective cough clearance and facilitating easier breathing.

Key Benefits of S PHYLLIN N:

  • Dual action: The combination of acebrophylline and acetylcysteine offers synergistic benefits, targeting both airway inflammation and mucus clearance to improve respiratory function comprehensively.
  • Symptom relief: Individuals with COPD or bronchial asthma experience relief from symptoms such as cough, sputum production, and dyspnea, leading to an improved quality of life.
  • Prevention of exacerbations: Regular use of S PHYLLIN N has been associated with a reduction in the frequency and severity of exacerbations, promoting disease stability and control.
  • Enhanced lung function: Acebrophylline and acetylcysteine contribute to improved lung function, optimizing airflow and respiratory efficiency.

Guidelines for Usage:

  • S PHYLLIN N should be used as prescribed by healthcare professionals, with dosage tailored to individual patient needs based on disease severity and response to treatment.
  • Administration of S PHYLLIN N may vary, with some formulations requiring oral ingestion while others may be administered via inhalation or intravenous infusion.
  • Regular monitoring by healthcare providers is crucial to assess treatment response, monitor for adverse effects, and make necessary adjustments to therapy.

Conclusion:

Acebrophylline (100mg) and Acetylcysteine (600mg), combined in the formulation of S PHYLLIN N, emerge as valuable therapeutic options for individuals grappling with respiratory conditions. Their dual action in reducing airway inflammation and facilitating mucus clearance offers comprehensive relief and improved respiratory function, paving the way for enhanced quality of life for patients with COPD and bronchial asthma.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW

SHARE WITH